Solifenacin for treating overactive bladder

Published on 01 Oct 2018
Last Updated on 01 Oct 2018

Guidance Recommendation

The Ministry of Health's Drug Advisory Committee has recommended:

• Solifenacin 5 mg tablet for treating overactive bladder.

Subsidy status

Solifenacin 5 mg tablet is recommended for inclusion on the MOH Standard Drug List (SDL).

Solifenacin for OAB (1 Oct 2018) [PDF, 447 KB]